About this resource:

HHS Non-systematic Review

Source: Food and Drug Administration, 2012

Last Reviewed: N/A

Workgroups: Food Safety Workgroup

Read more about this resource

Objectives related to this resource (2)

Prevent an increase in the proportion of nontyphoidal Salmonella infections that are resistant to multiple drug classes — FS‑05
Baseline only
Prevent an increase in the proportion of macrolide antibiotic-resistant Campylobacter infections — FS‑06
Baseline only

Suggested Citation

1.

U.S. Food and Drug Administration. (2012). 21 CFR part 530: New animal drugs; cephalosporin drugs; extralabel animal drug use; order of prohibition. Federal Register 77(4), 735-745. Retrieved from https://www.govinfo.gov/content/pkg/FR-2012-01-06/pdf/2012-35.pdf